Literature DB >> 8530801

Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS)

H P Allgaier, K Haag, A Ochs, K H Hauenstein, M Jeserich, T Krause, C Heilmann, W Gerok, M Rössle.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8530801     DOI： 10.1016/0168-8278(95)80318-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  15 in total

Review 1.  Hepatopulmonary syndrome.

Authors:  M B Fallon; G A Abrams
Journal:  Curr Gastroenterol Rep       Date:  2000-02

Review 2.  Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure.

Authors:  Michael C Wallace; Alan L James; Martin Marshall; Nickolas Kontorinis
Journal:  BMJ Case Rep       Date:  2012-06-01

Review 3.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

4.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

5.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

6.  Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome.

Authors:  Graciela Martinez-Palli; Britt B Drake; Joan-Carles Garcia-Pagan; Joan-Albert Barbera; Miguel R Arguedas; Robert Rodriguez-Roisin; Jaume Bosch; Michael B Fallon
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

7.  Hepatopulmonary syndrome.

Authors:  Miguel R Arguedas; Michael B Fallon
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

Review 8.  Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

Review 9.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 10.  Current use of transjugular intrahepatic portosystemic shunts.

Authors:  Timothy M McCashland
Journal:  Curr Gastroenterol Rep       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.